Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).

Bolton C, Wood EG, Ayoub SS.

Fundam Clin Pharmacol. 2013 Oct;27(5):535-43. doi: 10.1111/j.1472-8206.2012.01050.x. Epub 2012 Jun 29.

PMID:
22742874
2.

Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE).

Ayoub SS, Wood EG, Hassan SU, Bolton C.

Inflamm Res. 2011 Oct;60(10):919-28. doi: 10.1007/s00011-011-0352-3. Epub 2011 Jun 12.

PMID:
21667309
3.

Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.

Berard JL, Zarruk JG, Arbour N, Prat A, Yong VW, Jacques FH, Akira S, David S.

Glia. 2012 Jul;60(7):1145-59. doi: 10.1002/glia.22342. Epub 2012 Apr 12.

PMID:
22499213
5.

Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.

Grasselli G, Rossi S, Musella A, Gentile A, Loizzo S, Muzio L, Di Sanza C, Errico F, Musumeci G, Haji N, Fresegna D, Sepman H, De Chiara V, Furlan R, Martino G, Usiello A, Mandolesi G, Centonze D.

Br J Pharmacol. 2013 Jan;168(2):502-17. doi: 10.1111/j.1476-5381.2012.02178.x.

6.

Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.

Yin LL, Lin LL, Zhang L, Li L.

Neuropharmacology. 2012 Oct;63(5):851-62. doi: 10.1016/j.neuropharm.2012.06.025. Epub 2012 Jun 21.

PMID:
22728315
7.

Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.

van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf AF, Melief MJ, Hintzen RQ, 't Hart BA, Amor S, Boven LA, Laman JD.

J Pathol. 2009 Mar;217(4):543-51. doi: 10.1002/path.2476.

PMID:
19023878
9.

Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.

Kan QC, Zhang S, Xu YM, Zhang GX, Zhu L.

Neurosci Lett. 2014 Feb 7;560:92-7. doi: 10.1016/j.neulet.2013.12.031. Epub 2013 Dec 22.

PMID:
24368216
10.
11.
12.

Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.

Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, Glorioso JC, Comi G, Martino G.

Gene Ther. 2001 Jan;8(1):13-9.

13.

Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis.

Sulkowski G, Dąbrowska-Bouta B, Chalimoniuk M, Strużyńska L.

J Neuroimmunol. 2013 Aug 15;261(1-2):67-76. doi: 10.1016/j.jneuroim.2013.05.006. Epub 2013 Jun 6.

PMID:
23746391
14.

Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.

Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.

J Autoimmun. 2011 Nov;37(3):228-41. doi: 10.1016/j.jaut.2011.06.003. Epub 2011 Jul 14.

PMID:
21752599
15.

Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis.

Miljković Z, Momcilović M, Miljković D, Mostarica-Stojković M.

J Neuroinflammation. 2009 Dec 11;6:37. doi: 10.1186/1742-2094-6-37.

16.

Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.

Evonuk KS, Baker BJ, Doyle RE, Moseley CE, Sestero CM, Johnston BP, De Sarno P, Tang A, Gembitsky I, Hewett SJ, Weaver CT, Raman C, DeSilva TM.

J Immunol. 2015 Jul 15;195(2):450-63. doi: 10.4049/jimmunol.1401108. Epub 2015 Jun 12.

PMID:
26071560
18.

MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis.

Bolton C, Paul C.

J Pharmacol Exp Ther. 1997 Jul;282(1):397-402.

19.

The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.

Moliné-Velázquez V, Ortega MC, Vila del Sol V, Melero-Jerez C, de Castro F, Clemente D.

Neurobiol Dis. 2014 Jul;67:149-64. doi: 10.1016/j.nbd.2014.03.017. Epub 2014 Apr 5.

PMID:
24709559
20.

Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.

Mattner F, Staykova M, Berghofer P, Wong HJ, Fordham S, Callaghan P, Jackson T, Pham T, Gregoire MC, Zahra D, Rahardjo G, Linares D, Katsifis A.

J Nucl Med. 2013 Feb;54(2):291-8. doi: 10.2967/jnumed.112.108894. Epub 2013 Jan 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk